# Ozempic

Type: Product

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/ozempic
Canonical HTML page: https://getlegalbrief.com/entity/ozempic

## Timeline

- **2025**: First NAION lawsuits filed against GLP-1 makers in New Jersey — Patients begin filing lawsuits alleging that GLP-1 drugs such as Ozempic, Wegovy, and Zepbound caused permanent vision loss and that manufacturers failed to warn about the risk.

## Recent coverage (1 stories)

### Nearly 100 GLP-1 Vision Loss Suits in NJ Hinge on Causation Evidence
2026-09-24 00:14:01 · Sentiment: Negative · Impact: 7/10 · Sources: 2

Nearly 100 NAION lawsuits against Novo Nordisk and Eli Lilly test pharmaceutical failure-to-warn liability. Mixed epidemiological evidence and diabetes-related blindness risk create a dense causation battleground for mass tort litigators.
Full story: https://getlegalbrief.com/story/glp-1-naion-vision-loss-lawsuits-legal

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.